BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Gastroenterol. Feb 21, 2026; 32(7): 114773
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.114773
Table 1 Comparison of baseline and clinical characteristics among new-onset multi-organ failure, new-onset single organ failure, and organ failure groups, n (%)
Characteristics
NOOF (n = 38)
OF (n = 113)
P value1
P value2
NOMOF (n = 21)
NOSOF (n = 17)
Age, years, median (IQR)42 (35, 67)48 (35, 59)48 (37, 59)0.6630.791
Male10 (47.6)11 (64.7)55 (48.7)0.4820.292
BMI, mean ± SD25.6 ± 2.826.5 ± 2.826.4 ± 3.10.4660.332
Etiology0.1860.652
    Biliary10 (47.6)7 (41.2)33 (29.2)
    Hypertriglyceridemia7 (33.3)8 (47.1)52 (46.0)
    Others4 (19.0)2 (11.8)28 (24.8)
Severity
APACHE II score, median (IQR)14 (11, 19)16 (13, 20)11 (8, 14)< 0.001a0.263
BISAP score, median (IQR)3 (3, 4)3 (2, 3)2 (2, 3)0.001a0.117
CTSI score, median (IQR)8 (8, 10)8 (6, 10)4 (4, 6)< 0.001a0.348
MOF on admission12 (57.1)9 (52.9)19 (16.8)< 0.001a0.796
OF duration > 2 weeks19 (90.5)10 (58.8)17 (15.0)< 0.001a0.058
IPN19 (90.5)14 (82.4)19 (16.8)< 0.001a0.800
Major complications15 (71.4)11 (64.7)13 (11.5)< 0.001a0.658
Interventions
    Step-up approach14 (66.7)11 (64.7)20 (17.7)< 0.001a0.899
    OPN5 (23.8)3 (17.6)0 (0)< 0.001a0.950


Write to the Help Desk